Heart drug tested as migraine shield in small study
NCT ID NCT04853797
First seen Jan 09, 2026 · Last updated May 19, 2026 · Updated 23 times
Summary
This study tested whether ivabradine, a medicine that slows the heart rate, could prevent migraine attacks triggered by a substance called levcromakalim. Thirty-seven adults with migraine without aura took part. Researchers measured how many migraine attacks occurred after taking ivabradine compared to a placebo. The goal was to see if ivabradine could block the migraine-causing effects of levcromakalim.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIGRAINE WITHOUT AURA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Danish Headache Center
Glostrup Municipality, 2600, Denmark
-
Danish Headache Centre, Rigshospitalet-Glostrup
Glostrup, Region Sjælland, 2600, Denmark
Conditions
Explore the condition pages connected to this study.